US gov­ern­ment pledges $2B for new ini­tia­tive on bio­man­u­fac­tur­ing

Over the past few days, the Biden ad­min­is­tra­tion has been fo­cused on new sci­ence ef­forts, par­tic­u­lar­ly around can­cer, and grow­ing bio­man­u­fac­tur­ing in the US.

On Wednes­day, the White House held a sum­mit on biotech and bio­man­u­fac­tur­ing, re­veal­ing what it will spend to boost these ef­forts.

Bri­an Deese, di­rec­tor of the Na­tion­al Eco­nom­ic Coun­cil, said that the ad­min­is­tra­tion has been fo­cused on a mod­ern in­dus­tri­al strat­e­gy by plac­ing pub­lic funds in ef­forts that in­vest in in­fra­struc­ture and se­cure sup­ply chains. He al­so said that the fo­cus of the ini­tia­tive is to in­crease the do­mes­tic man­u­fac­tur­ing of APIs to lim­it the de­pen­dence on for­eign sup­pli­ers as well as in­crease the do­mes­tic man­u­fac­tur­ing ca­pac­i­ty in gen­er­al and cre­ate jobs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER